Research: Controlled therapeutic release of macromolecules possible

Sep 11, 2012

When a large volume of medication is the prescription, steady and controlled release of the drug sometimes is preferred by physicians over a "burst-release" treatment in which the substance is administered all at once. In recent years, researchers have developed numerous ways to administer substances in a controlled way, but doing so for therapeutics of large molecular size has been an elusive goal, especially when one needs nanoparticles for the delivery.

Researchers in the Department of  Bioengineering have developed a methodology that enables the constant release of over long periods of time—in fact, up to four weeks—potentially eliminating the problems often associated with bolus (or all-at-once) treatments.

The research team, led by Sanjib Bhattacharyya, a research associate in the lab of Professor Paul Ducheyne, combined mesoporous silica nanosphere (MSN) cores with a grafted biocompatible (PEG) polymer surface. The of the MSNs was then expanded, and a large model molecule, trypsin inhibitor (TI) with a molecular weight of 23,000 Da, was inserted. The researchers then tracked the release of TI macromolecules from the during a four-week period.

"The release approached a constant rate over the full duration of the experiment for pore-expanded MSNs, but not for the untreated MSNs," wrote the researchers whose work was published in the September issue of Acta Biomaterialia. "Among other benefits, it is apparent that the PEG coating successfully eliminated the initial burst exhibited by control samples without PEG film."

Bhattacharyya noted that the pore expansion and the amount of polymer used to coat the surface were critical factors in the experiment's success.

The research potentially points the way for improved administration of important therapeutics such as . "It's very hard to release molecules over such a long period of time," he said. "One of the big advantages to this system is that the substances can be released continuously for several weeks."

Said Ducheyne, "We are thinking about this not just for macromolecules. "Other ongoing work entails dual treatments, such as growth factor delivered in a scaffold and administered along with antibiotics to treat concomitant infections."

Explore further: Synthetic virus developed to deliver a new generation of medicines

Related Stories

Researchers use nanoparticles to shrink tumors in mice

Jul 09, 2010

(PhysOrg.com) -- The application of nanotechnology in the field of drug delivery has attracted much attention in recent years. In cancer research, nanotechnology holds great promise for the development of ...

PEGylated dendrimers: a novel mechanism of drug delivery

Mar 11, 2010

Monash Institute of Pharmaceutical Science (MIPS) researchers, in collaboration with the biotechnology company Starpharma Holdings Ltd have developed a new method to deliver medications that may benefit thousands of patients ...

A simple therapy for brain injury

Jun 27, 2008

Severe brain injury due to blunt force trauma could be reduced by application of a simple polymer, Polyethylene glycol or PEG, mixed in sterile water and injected into the blood stream – as reported in BioMed Central's ...

Recommended for you

Introducing the multi-tasking nanoparticle

Aug 26, 2014

Kit Lam and colleagues from UC Davis and other institutions have created dynamic nanoparticles (NPs) that could provide an arsenal of applications to diagnose and treat cancer. Built on an easy-to-make polymer, these particles ...

Tissue regeneration using anti-inflammatory nanomolecules

Aug 22, 2014

Anyone who has suffered an injury can probably remember the after-effects, including pain, swelling or redness. These are signs that the body is fighting back against the injury. When tissue in the body is damaged, biological ...

User comments : 0